期刊文献+

2014年河南省疑似预防接种异常反应监测 被引量:7

Analysis of surveillance results of adverse events following immunization in Henan Province in 2014
原文传递
导出
摘要 目的收集河南省2014年疑似预防接种异常反应(AEFI)报告情况,分析其特征,用于评价河南省AEFI监测系统敏感性、国家免疫规划(NIP)所用疫苗的安全性以及预防接种服务质量。方法对中国免疫规划监测信息管理系统中河南省2014年报告的AEFI个案数据进行收集,采用描述性方法对相关指标进行流行病学分析。结果河南省2014年共报告AEFI个案5 114例,报告发生率10.91/10万,男性为2 944例,占57.57%;1岁以下患儿为2 348例,占报告总数的45.91%;4—9月是AEFI报告较多的月份,其中8月份报告最多;郑州、开封、洛阳等16个省辖市每个月均报告了AEFI病例;涉及到的疫苗分别为百白破(无细胞)1471例、含麻807例、乙脑(减毒)594例,绝大多数AEFI病例预后良好。结论全省AEFI异常反应主要发生在1岁以下小年龄组儿童,涉及疫苗主要为百白破(无细胞)疫苗,预防接种服务人员和儿童监护人应密切关注。 Objective To understand the characteristics of adverse events following immunization(AEFI), so as to evaluate the sensitivity of surveillance system, the safety of vaccines covered by national immunization program(NIP), and the quality of immunization services. Methods The data reported from Jan 1, 2014 t o Dec 31, 2014 were collected through the China Information System for NIP Surveillance and analyzed with the epidemiologic descriptive method. Results There were 5 114 cases of AEFI reported in 2014, with an incidence of 10.91/ 105. There were 2 944 male cases(57.57%) and 2348 infants aged below 1 year(45.91%). The peak time of AEFI reports was from April to September, and August had the most reported cases. Zhengzhou, Kaifeng, Luoyang and other 16 provincial cities reported AEFI cases every month. There were 1 471 AEFI cases being related to DPT vaccination, 807 to measles vaccination, and 594 to live attenuated JE vaccination, and most of AEFI cases had good prognosis. Conclusion AEFI occurs mostly to young children and mainly relates to DPT vaccination. Therefore, young children should be the focus of AEFI surveillance.
出处 《中国校医》 2015年第12期934-937,共4页 Chinese Journal of School Doctor
关键词 疫苗/不良反应 接种/不良反应 公共卫生监测 Vaccines/adverse effects Vaccination/adverse effects Public Health Surveillance.
  • 相关文献

参考文献10

二级参考文献86

  • 1吴殚,王凤双,肖雷.北京市顺义区2008~2010年疑似预防接种异常反应监测分析[J].现代预防医学,2012,39(22):5969-5971. 被引量:16
  • 2郭飚,曹雷,曹玲生,徐立君,梁晓峰,张振国,罗耀星,孙印旗,彭国文,赵占杰.河北、广东省预防接种副反应监测试点培训效果评估[J].中国计划免疫,2005,11(4):302-305. 被引量:34
  • 3卫生部.全国疑似预防接种异常反应监测方案[S].2009.
  • 4卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].2010-06-03.
  • 5郭玉璞,王维冶.神经病学[M].北京:人民卫生出版社,2006,1223,1224,1272
  • 6中华人民共和国国务院.疫苗流通和预防接种管理条例.2005.3.
  • 7WPRO. Immunization Safety surveillance: Guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization [ S ]. Philippines, Manila, 1999.
  • 8WHO. Supplementary information on vaccine safety, part2: background rates of adverse events following immunization[S]. Swiss, Geneva,2000.
  • 9S E Tarvin, S Ballinger. Henoch-Schonlein purpura[J]. Current Paediatrics, 2006, 16, 259-263.
  • 10J M M Gardner-Medwin, P Dolezalova, C Cummins, et al. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins [J]. Lancet, 2002, 360:1197-1202.

共引文献249

同被引文献58

引证文献7

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部